| 1 |
中华人民共和国卫生部. 中国出生缺陷防治报告（2012）. 2012.
|
| 2 |
Liehr T, Weise A, Hamid AB, et al. Multicolor FISH methods in current clinical diagnostics[J]. Expert Rev Mol Diagn, 2013,13(3):251-255.
|
| 3 |
Hills A, Donaghue C, Waters J, et al. QF-PCR as a stand-alone test for prenatal samples: the first 2 years' experience in the London region[J].Prenat Diagn, 2010, 30(6): 509-517.
|
| 4 |
Holgado E, Liddle S, Ballard T, et al. Incidence of placental mosaicism leading to discrepant results between QF-PCR and karyotyping in 22,825 chorionic villus samples[J]. Prenat Diagn, 2011, 31(11): 1029-1038.
|
| 5 |
Mann K, Ogilvie CM. QF-PCR: application, overview and review of the literature[J]. Prenat Diagn, 2012, 32(4): 309-314.
|
| 6 |
Boormans EM, Birnie E, Oepkes D, et al. Comparison of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis[J]. Obstet Gynecol, 2010, 115(2 Pt 1): 297-303.
|
| 7 |
Chitty LS, Kistler J, Akolekar R, et al. Multiplex ligation-dependent probe amplification (MLPA): a reliable alternative for fetal chromosome analysis?[J]. J Matern Fetal Neonatal Med, 2012, 25(8): 1383-1386.
|
| 8 |
Kjaergaard S, Sundberg K, Jørgensen F, et al. Diagnostic yield by supplementing prenatal metaphase karyotyping with MLPA for microdeletion syndromes and subtelomere imbalances[J]. Prenat Diagn, 2010, 30(10): 995-999.
|
| 9 |
Konialis C, Hagnefelt B, Sevastidou S, et al. Uncovering recurrent microdeletion syndromes and subtelomeric deletions/duplications through non-selective application of a MLPA-based extended prenatal panel in routine prenatal diagnosis[J]. Prenat Diagn, 2011, 31(6): 571-577.
|
| 10 |
Miller DT, Adam MP, Aradhya S, et al. Consensus Statement:Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies[J]. Am J Hum Genet, 2010, 86(5): 749-764.
|
| 11 |
Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarraybased comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies[J]. Prenat Diagn, 2012, 32(10): 976-985.
|
| 12 |
Srebniak MI, Boter M, Oudesluijs GO, et al. Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalities[J]. Mol Cytogenet, 2012, 5(1): 14-17.
|
| 13 |
Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis[J]. N Engl J Med, 2012, 367(23):2175-2184.
|
| 14 |
Reddy UM, Page GP, Saade GR, et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth[J]. N Engl J Med,2012, 367(23): 2185-2193.
|
| 15 |
傅启华, 郑昭璟. 基于染色体芯片分析的产前诊断[J]. 中华检验医学杂志, 2013, 36(1): 6-10.
|
| 16 |
Wapner RJ, Driscoll DA, Simpson JL. Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial[J]. Prenat Diagn, 2012, 32(4): 396-400.
|
| 17 |
郑昭璟, 傅启华. 下一代测序技术在单基因遗传性疾病分子诊断中的应用[J]. 诊断学理论与实践, 2013, 12(4): 390-395.
|
| 18 |
Greene MF, Phimister EG. Screening for trisomies in circulating DNA[J]. N Engl J Med, 2014, 370(9): 874-875.
|
| 19 |
Morain S, Greene MF, Mello MM. A New Era in Noninvasive Prenatal Testing[J]. N Engl J Med, 2013, 369(6): 499-501.
|
| 20 |
Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening[J]. N Engl J Med, 2014,370(9): 799-808.
|
| 21 |
Bianchi DW, Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?[J]. Clin Chem, 2014, 60(1): 78-87.
|
| 22 |
You Y, Sun Y, Li X, et al. Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease[J]. Genet Med, 2014, 16(8): 594-600.
|
| 23 |
Meng M, Li X, Ge H, et al. Noninvasive prenatal testing for autosomal recessive conditions by maternal plasma sequencing in a case of congenital deafness[J]. Genet Med, 2014, Epub ahead of print.
|
| 24 |
New MI, Tong YK, Yuen T, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma[J]. J Clin Endocrinol Metab, 2014, 99(6): E1022-E1030.
|
| 25 |
Lam KWG, Jiang P, Liao GJ, et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia[J]. Clin Chem, 2012,58(10): 1467-1475.
|
| 26 |
Kitzman JO, Snyder MW, Ventura M, et al. Noninvasive whole-genome sequencing of a human fetus[J]. Sci Transl Med, 2012, 4(137): 137ra76.
|
| 27 |
Lo YD. Noninvasive fetal whole-genome sequencing from maternal plasma: feasibility studies and future directions[J]. Clin Chem, 2013,59(4): 601-603.
|
| 28 |
Fan HC, Gu W, Wang J, et al. Non-invasive prenatal measurement of the fetal genome[J]. Nature, 2012, 487(7407): 320-324.
|
| 29 |
Talkowski ME, Ordulu Z, Pillalamarri V, et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample[J]. N Engl J Med,2012, 367(23): 2226-2232.
|
| 30 |
傅启华, 郑昭璟. 新生儿遗传代谢性疾病的实验室筛查与诊断[J].中华检验医学杂志, 2014, 37(4): 1-4.
|
| 31 |
陈文祥. 我国临床检验外部质量控制概况[J/CD]. 中华临床实验室管理电子杂志, 2013, 1(1): 9-12.
|
| 32 |
杨正华. 加强医学实验室技术能力做好实验室认可[J/CD]. 中华临床实验室管理电子杂志, 2013, 1(1): 13-16.
|